Related Experiment Video
Updated: Dec 15, 2025

Assessing Cellular Target Engagement by SHP2 PTPN11 Phosphatase Inhibitors
Published on: July 17, 2020
Good Guy in Bad Company: How STRNs Convert PP2A into an Oncoprotein
Kari J Kurppa1, Jukka Westermarck2
1MediCity Research Laboratories, University of Turku, Turku, Finland; Institute of Biomedicine, University of Turku, Turku, Finland.
Abstract:
Certain Protein Phosphatase 2A (PP2A) complexes are human tumor suppressors. In contrast, a paper in this issue of Cancer Cell and two other recent studies demonstrate that PP2A-STRN3/4 complexes inactivate Hippo tumor suppressor pathway, resulting in YAP activation and tumorigenesis. Furthermore, this new oncogenic phosphatase mechanism may be druggable.
Related Concept Videos
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein....
Abnormal Proliferation
PI3K/mTOR/AKT Signaling Pathway
Amplifying Signals via Enzymatic Cascade
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle

